2019
DOI: 10.1017/cjn.2019.5
|View full text |Cite
|
Sign up to set email alerts
|

Psychiatric Neurosurgery: A Survey on the Perceptions of Psychiatrists and Residents

Abstract: ABSTRACT:Objectives: To evaluate the attitudes and perceptions of psychiatrists and psychiatry residents regarding neurosurgical procedures for treating psychiatric disorders and to identify potential barriers to patient referral. Methods: A survey consisting of 25 questions was created using SurveyMonkey and was distributed to psychiatrists and psychiatry residents in Quebec. The study was approved by the McGill University Health Center’s Research Ethics Board. Descriptive statistics and Friedman’s test were … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(18 citation statements)
references
References 34 publications
0
18
0
Order By: Relevance
“…However, as the hypotheses concerning particular disorders vary, so do the stimulation targets: OCD (7 targets tested), MDD (7), Tourette's (6), anorexia nervosa (4), addiction (3), anxiety (2), obesity (2) and post‐traumatic stress disorder (PTSD) (1) (Lee et al., 2019). To date, DBS treatment has been approved only for OCD (receiving a Humanitarian Device Exemption from the Food and Drug Administration (FDA) in 2008 to target the anterior limb of the internal capsule); stimulation in other psychiatric disorders, including Depression, fall under the “investigational” trial category (for summary of results, see Cleary et al., 2015; Cormier et al., 2019; Graat et al., 2017; Lee et al., 2019).…”
Section: Psychiatric Disorders and Dbsmentioning
confidence: 99%
“…However, as the hypotheses concerning particular disorders vary, so do the stimulation targets: OCD (7 targets tested), MDD (7), Tourette's (6), anorexia nervosa (4), addiction (3), anxiety (2), obesity (2) and post‐traumatic stress disorder (PTSD) (1) (Lee et al., 2019). To date, DBS treatment has been approved only for OCD (receiving a Humanitarian Device Exemption from the Food and Drug Administration (FDA) in 2008 to target the anterior limb of the internal capsule); stimulation in other psychiatric disorders, including Depression, fall under the “investigational” trial category (for summary of results, see Cleary et al., 2015; Cormier et al., 2019; Graat et al., 2017; Lee et al., 2019).…”
Section: Psychiatric Disorders and Dbsmentioning
confidence: 99%
“…These concerns may originate, in part, from the widespread mis-use and abuse of psychiatric surgery in the 1950s 27,28 . Despite the significant advances in the field (e.g., the advent of stereotaxy, MRI-guided targeting, and more strict ethical oversight), lesional procedures are still viewed as risky or dangerous by a substantial proportion of psychiatrists 29 and the general public 30 . Although numerous recent RF and SRS trials have been effective at improving psychiatric symptoms, several of these studies reported persistent postoperative difficulties on cognitive tasks, particularly on tests of executive function [31][32][33][34][35] .…”
Section: Introductionmentioning
confidence: 99%
“…In this phase, we wanted to explore participants’ experiences of being informed of the diagnosis and how that information was shared in the family. Data security of this sensitive information was ensured through (SG’s) password protected access to the responses submitted via SurveyMonkey, a platform considered sufficiently secure for health related surveys [ 62 , 63 , 64 ] and approved by the Ethics Committee within the study protocol [ 60 ].…”
Section: Methodsmentioning
confidence: 99%